Bonviva Articles
Two US FDA advisory panels say osteoporosis drugs need label changes
12 September 2011
Bisphosphonates under scrutiny in Europe over link to stress fractures
28 September 2010
Showing 1-3 of 3 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
